| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 721045 | Null | 0.029334167004364 | 0.34799628 |
| NSC 741909 | 1H-Indole-3-methanol, 1-[(4-chlorophenyl)methyl]- | 0.029334167004364 | 0.11685627 |
| NSC 757933 | 1,3-diphenyl-4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-1H-pyrazole | 0.0293341670043647 | -0.28751374 |
| NSC 751902 | 2-4-[5-(3,4-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,7-dimethoxy-1,3-benzothiazole | 0.0293341670043648 | 0.41158595 |
| NSC 749160 | Null | 0.0295480456086945 | 0.68030963 |
| NSC 751830 | 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one | 0.0295480456086945 | 0.15326609 |
| NSC 76150 | Null | 0.0295480456086945 | 0.15385362 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0295480456086947 | 0.31142303 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0295480456086947 | 0.26862275 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.0295480456086947 | 0.6288805 |